L. Christie

Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.

Dean M. Messing, G. Anderson, J. Monahan, 2011, Bioorganic & medicinal chemistry letters.

Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.

R. Kurumbail, J. Monahan, M. Hepperle, 2009, Bioorganic & medicinal chemistry letters.

Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats

Mark B. Anderson, G. Paderes, D. Luthin, 2003, Journal of Pharmacology and Experimental Therapeutics.

Effect of Testosterone Suppression on the Pharmacokinetics of a Potent GnRH Receptor Antagonist

Mark B. Anderson, D. Luthin, K. Anderes, 2002, Pharmaceutical Research.

Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.

R. Kurumbail, Dean M. Messing, J. F. Schindler, 2011, Bioorganic & medicinal chemistry letters.

Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.

K. Ogilvie, Guy A. McClellan, L. Christie, 2006, Bioorganic & medicinal chemistry letters.

The discovery of novel small molecule non-peptide gonadotropin releasing hormone (GnRH) receptor antagonists.

Mark B. Anderson, G. Paderes, D. Luthin, 2002, Bioorganic & medicinal chemistry letters.

Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.

Mark B. Anderson, G. Paderes, D. Luthin, 2006, Journal of medicinal chemistry.

Electrophilic tetraalkylammonium nitrate nitration. II. Improved anhydrous aromatic and heteroaromatic mononitration with tetramethylammonium nitrate and triflic anhydride, including selected microwave examples.

Mark B. Anderson, L. Christie, Haitao Li, 2003, Journal of Organic Chemistry.